ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2016. The put-call ratio across all filers is 9.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $80,868,000 | -18.5% | 16,013,540 | 0.0% | 4.56% | +23.4% |
| Q3 2017 | $99,284,000 | +72.2% | 16,013,540 | 0.0% | 3.70% | +140.4% |
| Q2 2017 | $57,649,000 | +10.8% | 16,013,540 | 0.0% | 1.54% | -4.8% |
| Q1 2017 | $52,044,000 | +32.7% | 16,013,540 | 0.0% | 1.62% | +35.6% |
| Q4 2016 | $39,233,000 | -28.8% | 16,013,540 | 0.0% | 1.19% | -42.6% |
| Q3 2016 | $55,087,000 | -43.5% | 16,013,540 | 0.0% | 2.08% | -37.9% |
| Q3 2015 | $97,522,000 | – | 16,013,540 | – | 3.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |